Stocklytics Platform
Asset logo for symbol TECH
Bio-Techne
TECH53
$73.03arrow_drop_up0.37%$0.27
S&P500
Asset logo for symbol TECH
TECH53

$73.03

arrow_drop_up0.37%

Performance History

Chart placeholder
Key Stats
Open$72.63
Prev. Close$72.74
EPS0.95
Next Earnings DateFeb 14, 2025
LOWHIGH
Day Range71.88
74.22
52 Week Range51.79
85.57
Ratios
EPS0.95

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Bio-Techne (TECH)

Bio-Techne Corp (TECH) is a leading provider of innovative life science tools and services. The company operates in two segments: Protein Sciences and Diagnostics. It offers a wide range of products, including antibodies, proteins, immunoassays, and RNA-sequencing kits, which are used by researchers and scientists worldwide. Bio-Techne's products are used in various applications, such as drug discovery, diagnostics, and personalized medicine. The company has a strong track record of innovation and has been awarded numerous patents for its technologies.
Bio-Techne Corp has a market cap of $15.4 billion and a PEG ratio of 2.86. Its stock price has shown strong performance over the past year, with a 52-week range of $160.52 to $317.82. The stock is currently trading at $295.68, near its all-time high. The company has a high trading volume, indicating strong investor interest. Bio-Techne Corp's financial performance has been impressive, with strong revenue growth and profitability. Its revenue for the last fiscal year was $893 million, with a net income of $210 million.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Charles R. Kummeth
Headquarters
Minneapolis
Employees
3000
Exchange
NASDAQ
add Bio-Techne to watchlist

Keep an eye on Bio-Techne

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Bio-Techne's (TECH) price per share?

The current price per share for Bio-Techne (TECH) is $73.03. The stock has seen a price change of $0.27 recently, indicating a 0.37% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Bio-Techne (TECH)?

For Bio-Techne (TECH), the 52-week high is $85.57, which is 17.17% from the current price. The 52-week low is $51.79, the current price is 41.01% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Bio-Techne (TECH) a growth stock?

Bio-Techne (TECH) has shown an average price growth of -5.34% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bio-Techne as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Bio-Techne (TECH) stock price performance year to date (YTD)?

As of the latest data, Bio-Techne (TECH) has a year-to-date price change of -4.8%. Over the past month, the stock has experienced a price change of -1.83%. Over the last three months, the change has been -5.41%. Over the past six months, the figure is -1.96%. Looking at a longer horizon, the five-year price change stands at -67.06%.
help

Is Bio-Techne (TECH) a profitable company?

Bio-Techne (TECH) has a net income of $168.07M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 66.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.16B, with a revenue growth rate of 1.97%, providing insight into the company's sales performance and growth. The gross profit is $769.72M. Operating income is noted at $206.69M. Furthermore, the EBITDA is $339.2M.
help

What is the market capitalization of Bio-Techne (TECH)?

Bio-Techne (TECH) has a market capitalization of $11.6B. The average daily trading volume is 73.02, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level